Communication Bridge for Primary Progressive Aphasia (CB3_1 Trial)

N/A

Waitlist Available

Led By Emily Roglaski, PhD

Research Sponsored by University of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

A dementia diagnosis other than Primary Progressive Aphasia

Timeline

Screening 3 weeks

Treatment Varies

Follow Up time frame: 2 assessment time points through study completion, an average of 5 months, including change over time

Awards & highlights

No Placebo-Only Group

Summary

This trial is looking at how well certain treatments work for people with mild to moderate primary progressive aphasia. The treatments focus on improving communication skills.

Who is the study for?

This trial is for adults with mild to moderate primary progressive aphasia (PPA) or related conditions. Participants must speak English, have good enough vision and hearing for daily tasks, be able to use video conferencing and a web app, and not be too depressed based on a scale. Their communication partners also need to meet similar criteria.

What is being tested?

The study tests the 'Communication Bridge' intervention's effectiveness in improving communication abilities in individuals with PPA. It involves using evidence-based methods delivered through technology like video calls and a specialized web application.

What are the potential side effects?

Since this trial focuses on non-drug interventions involving speech therapy techniques and technology use, traditional medication side effects are not expected. However, participants may experience frustration or fatigue during therapy sessions.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My dementia diagnosis is not Primary Progressive Aphasia.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ time frame: 2 assessment time points through study completion, an average of 5 months, including change over time

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~time frame: 2 assessment time points through study completion, an average of 5 months, including change over time

This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame: 2 assessment time points through study completion, an average of 5 months, including change over time for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Communication Participation Person Centered Goals

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Communication Bridge™Experimental Treatment1 Intervention

Participants receive Communication Bridge™, a multi-component, participation-focused, dyadic intervention in which both the person with PPA and their co-enrolled communication partner are intervention recipients. Communication Bridge™ is modelled on the Living with Aphasia: Framework for Outcome Measurement (A-FROM) and the Care Pathway Model that was developed for persons living with primary progressive aphasia. Consistent with participation-focused intervention models personally salient training stimuli are incorporated into all therapy activities in the Experimental arm.

0 / 1Eligibility criteria met